Yuanta Securities Investment Consulting Co (元大投顧) yesterday downgraded its rating on TaiMed Biologics Inc (中裕新藥) to “hold” from “buy,” citing concerns over the company’s choice of distribution partner for its new HIV/AIDS drug TMB355.
TaiMed on Friday last week announced that it has signed a 12 year exclusive collaboration agreement with Montreal-based Theratechnologies Inc to market and distribute TMB355 in the US and Canada.
However, the market was expecting TaiMed to partner with GlaxoSmithKline PLC and Pfizer Inc, which jointly established ViiV Healthcare in 2009 — a company specializing in in the development of HIV therapies — Yuanta analyst Peggy Lee (李珮菁) said in a note published yesterday.
“We feel that the choice of partner represents the best balance between operating scale and payment obligation terms,” Lee said.
Under the deal with Theratechnologies, TaiMed is to be paid US$1 million in cash and US$2 million in the Canadian company’s stocks this year, Lee said.
For next year, the Canadian company is to pay US$1 million in stocks and an extra US$5.5 million in cash, while TaiMed is to receive 52 percent of the drug’s net sales.
That compares with a previous expectation of US$15 million upon signing and an additional US$5 million upon regulatory approval this year, as well as US$25 million in milestone cash payments and 50 percent of net profits of the drug for the next year.
Due to TaiMed’s distribution partner selection, expected earnings per share (EPS) has been slashed from NT$1.25 to a loss of NT$0.67 per share for this year and from an EPS of NT$1.95 to a loss of NT$0.39 for next year, Lee said.
The Canadian company reported sales of C$30 million (US$22.97 million) for last year and its market capitalization stood at around US$93 million dollars, Lee said, adding that Theratechnologies’ scale might be too small.
“We will be watching if Theratechnologies bundles the TMB355 with EGRIFTA, a treatment for HIV-associated abdominal lipohypertrophy, and whether it will transfer the package to larger international pharmaceutical players,” Lee said.
Despite the outcome, Lee said that the partnership has set a roadmap toward the drug’s commercialization once TMB355, also known as Ibalizumab, receives regulatory approval.
Meanwhile, TaiMed president and chief executive officer James Chang (張念原) said that he is upbeat on the more favorable percentage of sales terms offered by the Canadian, compared with other sector giants.
Taiwan Transport and Storage Corp (TTS, 台灣通運倉儲) yesterday unveiled its first electric tractor unit — manufactured by Volvo Trucks — in a ceremony in Taipei, and said the unit would soon be used to transport cement produced by Taiwan Cement Corp (TCC, 台灣水泥). Both TTS and TCC belong to TCC International Holdings Ltd (台泥國際集團). With the electric tractor unit, the Taipei-based cement firm would become the first in Taiwan to use electric vehicles to transport construction materials. TTS chairman Koo Kung-yi (辜公怡), Volvo Trucks vice president of sales and marketing Johan Selven, TCC president Roman Cheng (程耀輝) and Taikoo Motors Group
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
New apartments in Taiwan’s major cities are getting smaller, while old apartments are increasingly occupied by older people, many of whom live alone, government data showed. The phenomenon has to do with sharpening unaffordable property prices and an aging population, property brokers said. Apartments with one bedroom that are two years old or older have gained a noticeable presence in the nation’s six special municipalities as well as Hsinchu county and city in the past five years, Evertrust Rehouse Co (永慶房產集團) found, citing data from the government’s real-price transaction platform. In Taipei, apartments with one bedroom accounted for 19 percent of deals last
RECORD-BREAKING: TSMC’s net profit last quarter beat market expectations by expanding 8.9% and it was the best first-quarter profit in the chipmaker’s history Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), which counts Nvidia Corp as a key customer, yesterday said that artificial intelligence (AI) server chip revenue is set to more than double this year from last year amid rising demand. The chipmaker expects the growth momentum to continue in the next five years with an annual compound growth rate of 50 percent, TSMC chief executive officer C.C. Wei (魏哲家) told investors yesterday. By 2028, AI chips’ contribution to revenue would climb to about 20 percent from a percentage in the low teens, Wei said. “Almost all the AI innovators are working with TSMC to address the